IL2 and rheumatoid arthritis: Low-dose IL-2 at 0.5 million IU was widely used in the treatment of several autoimmune diseases, such as systemic lupus erythematosus (20, 21), psoriatic arthritis (22), and RA (16), but not refractory RA.